Veeva Systems Inc. (NYSE:VEEV) Shares Acquired by Trilogy Capital Inc.

Trilogy Capital Inc. grew its stake in Veeva Systems Inc. (NYSE:VEEV - Free Report) by 26.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 9,202 shares of the technology company's stock after acquiring an additional 1,896 shares during the period. Trilogy Capital Inc.'s holdings in Veeva Systems were worth $1,935,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. MassMutual Private Wealth & Trust FSB increased its holdings in Veeva Systems by 72.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company's stock worth $25,000 after purchasing an additional 50 shares during the period. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in shares of Veeva Systems during the third quarter worth approximately $26,000. True Wealth Design LLC raised its holdings in Veeva Systems by 3,375.0% in the third quarter. True Wealth Design LLC now owns 139 shares of the technology company's stock valued at $29,000 after acquiring an additional 135 shares in the last quarter. Retirement Wealth Solutions LLC purchased a new position in Veeva Systems in the fourth quarter worth approximately $31,000. Finally, Harvest Fund Management Co. Ltd acquired a new position in Veeva Systems during the 3rd quarter worth approximately $49,000. 88.20% of the stock is owned by hedge funds and other institutional investors.

Veeva Systems Trading Up 0.3 %

Shares of Veeva Systems stock traded up $0.73 on Monday, reaching $237.93. 337,928 shares of the stock were exchanged, compared to its average volume of 999,451. Veeva Systems Inc. has a 1-year low of $170.25 and a 1-year high of $258.93. The business has a fifty day moving average price of $224.48 and a two-hundred day moving average price of $214.76. The firm has a market capitalization of $38.63 billion, a PE ratio of 58.74, a PEG ratio of 1.97 and a beta of 0.85.

Insider Transactions at Veeva Systems

In other Veeva Systems news, SVP Jonathan Faddis sold 1,694 shares of the company's stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $230.30, for a total transaction of $390,128.20. Following the transaction, the senior vice president now directly owns 8,061 shares in the company, valued at approximately $1,856,448.30. This represents a 17.37 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 10.50% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on VEEV shares. JPMorgan Chase & Co. boosted their target price on shares of Veeva Systems from $208.00 to $218.00 and gave the stock a "neutral" rating in a research note on Monday, December 16th. Citigroup boosted their target price on shares of Veeva Systems from $281.00 to $307.00 and gave the stock a "buy" rating in a research note on Monday, December 9th. Truist Financial lowered their target price on shares of Veeva Systems from $261.00 to $210.00 and set a "hold" rating for the company in a research note on Monday, January 13th. The Goldman Sachs Group downgraded shares of Veeva Systems from a "buy" rating to a "sell" rating and lowered their target price for the stock from $261.00 to $200.00 in a research note on Thursday, January 23rd. Finally, Morgan Stanley boosted their target price on shares of Veeva Systems from $183.00 to $195.00 and gave the stock an "underweight" rating in a research note on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and seventeen have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $253.96.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.